Dec 9, 2020
What lies ahead for patients, your organisation and your workforce? In this podcast, we explore our predictions for the life sciences and health care industry in 2025, how the pandemic has accelerated industry trends and what this means for you.
Our host Karen Taylor, who leads Deloitte Centre for Health Solutions,...
Nov 12, 2020
C-suite leaders in pharmaceutical companies increasingly view Real World Evidence (RWE) as strategically important. RWE enables R&D organisations to prioritise their pipeline investments more effectively, better understand underlying causes of disease and identify opportunities for indication expansion and...
Sep 30, 2020
Healthcare systems across Europe face rising pressures – particularly the increasing healthcare needs due to growing and ageing populations, multi-morbidity, and public expectations of more personalised and convenient services. Many clinicians are struggling to cope with increasing workloads, and the gap between the...
Aug 27, 2020
The Biotech sector is a key player in driving biopharma innovation and developing ground-breaking treatments for patients. Supporting the growth of this sector is vital to ensure that R&D efforts continue, both now and in the future. However, like most industries, this sector faces a complex set of challenges.
Over the...
Jul 30, 2020
The COVID-19 pandemic has brought the Life Sciences Industry to an inflection point. It has exposed the limitations of traditional linear supply chain models, highlighted the need for sustainability and accelerated the move towards digital transformation.
Will the COVID-19 pandemic act as a catalyst for...